News
VTCRC Tenant Luminary Therapeutics to Develop Allogeneic CAR T Therapy for Targeting Solid Tumors
The Virginia Tech Corporate Research Center (VTCRC) is a hub for groundbreaking research and innovation, fostering partnerships that drive advancements in health sciences and biotechnology. As part of this ecosystem of cutting-edge developments, Luminary Therapeutics is making significant strides in the field of cellular therapies. With a strong focus on addressing the limitations of current CAR T treatments for solid tumors, Luminary’s latest funding award from the Advanced Research Projects Agency for
S1P Therapeutics Receives Prestigious Virginia Catalyst Grant for Kidney Disease Research
We are thrilled to congratulate S1P Therapeutics Inc. on receiving a prestigious Virginia Catalyst grant to support their innovative research into treatments for kidney and autoimmune diseases. This recognition underscores the impactful work of S1P Therapeutics and their commitment to improving the lives of patients suffering from Acute Kidney Injury (AKI) and Chronic Kidney Disease (CKD). S1P Therapeutics is pioneering a novel therapeutic target by blocking Spns2-dependent S1P transport to address
Find Your Ideal Workspace at VTCRC: Build-to-Suit, Coworking, and Shared Labs
The Virginia Tech Corporate Research Center (VTCRC) offers a variety of workspace solutions designed to meet the diverse needs of growing businesses, startups, and established companies. Whether you're looking for a custom-built headquarters, a flexible coworking space, or access to state-of-the-art shared labs, VTCRC has the perfect environment to support your success.Build-to-Suit Opportunities For companies looking for a long-term home tailored to their unique needs, VTCRC provides build-to-suit
